Paclitaxel and carboplatin for large cell neuroendocrine carcinoma of the uterine cervix

Journal of Obstetrics and Gynaecology Research

Volumn 33, Issue 2, 2007, Pages 218-224

  Tangjitgamol, Siriwan ^a   Manusirivithaya, Sumonmal ^a   Choomchuay, Nantana ^b   Leelahakorn, Surawute ^a   Thawaramara, Thaowalai ^a   Pataradool, Kamol ^a   Suekwatana, Pacheun ^a  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

Author keywords

Cervix; Large cell neuroendocrine carcinoma; Paclitaxel and carboplatin

Indexed keywords

CARBOPLATIN; CISPLATIN; ETOPOSIDE; PACLITAXEL;

ADRENAL METASTASIS; ADULT; ARTICLE; ASPIRATION BIOPSY; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE INTERVAL; DRUG RESPONSE; DRUG SUBSTITUTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; LABORATORY TEST; LARGE CELL CARCINOMA; LIVER METASTASIS; LYMPH NODE METASTASIS; MULTIPLE CYCLE TREATMENT; NEUROENDOCRINE TUMOR; OVARY TUMOR; RECURRENT DISEASE; SALPINGOOOPHORECTOMY; UNSPECIFIED SIDE EFFECT; UTERINE CERVIX CARCINOMA;

ADULT; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; CARBOPLATIN; CARCINOMA, LARGE CELL; CARCINOMA, NEUROENDOCRINE; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FATAL OUTCOME; FEMALE; HUMANS; LIVER NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; OVARIECTOMY; PACLITAXEL; UTERINE CERVICAL NEOPLASMS;

EID: 33847713390     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00509.x     Document Type: Article

References (24)

1. Albores-Saavedra J, Gersell D, Gilks CB et al. Terminology of endocrine tumors of the uterine cervix. Results of a workshop sponsored by the College of American Pathologists and the National Cancer Institute. Arch Pathol Lab Med 1997; 121: 34-39.
2. Sevin BU, Method MW, Nadji M, Lu Y, Averette HA. Efficacy of radical hysterectomy as treatment for patients with small cell carcinoma of the cervix. Cancer 1996; 77: 1489-1493.
3. Chan JK, Loizzi V, Burger RA, Rutgers J, Monk BJ. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 2003; 97: 568-574.
4. Gilks CB, Young RH, Gersell DJ, Clement PB. Large cell neuroendocrine (corrected) carcinoma of the uterine cervix: a clinicopathologic study of 12 cases. Am J Surg Pathol 1997; 21: 905-914.
5. Krivak TC, McBroom JW, Sundborg MJ, Crothers B, Parker MF. Large cell neuroendocrine cervical carcinoma: a report of two cases and review of the literature. Gynecol Oncol 2001; 82: 187-191.
6. Sato Y, Shimamoto T, Amada S, Asada Y, Hayashi T. Large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathological study of six cases. Int J Gynecol Pathol 2003; 22: 226-230.
7. Tsou MH, Tan TD, Cheng SH, Chiou YK. Small cell carcinoma of the uterine cervix with large cell neuroendocrine carcinoma component. Gynecol Oncol 1998; 68: 69-72.
8. Rhemtula H, Grayson W, van Iddekinge B, Tiltman A. Largecell neuroendocrine carcinoma of the uterine cervix - a clinicopathological study of five cases. S Afr Med J 2001; 91: 525-528.
9. Dikmen Y, Kazandi M, Zekioglu O, Ozsaran A, Terek MC, Erhan Y. Large cell neuroendocrine carcinoma of the uterine cervix: a report of a case and review of the literature. Arch Gynecol Obstet 2004; 270: 185-188.
10. Yamamoto R, Okamoto K, Yukiharu T et al. A study of risk factors for ovarian metastases in stage Ib-IIIb cervical carcinoma and analysis of ovarian function after a transposition. Gynecol Oncol 2001; 82: 312-316.
11. Nakanishi T, Wakai K, Ishikawa H et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 2001; 82: 504-509.
12. Young RH, Gersell DJ, Roth LM, Scully RE. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases. Cancer 1993; 71: 407-418.
13. Boruta DM, Schorge JO, Duska LA, Crum CP, Castrillon DH, Sheets EE. Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix. Gynecol Oncol 2001; 81: 82-87.
14. Cui S, Lespinasse P, Cracchiolo B, Sama J, Kreitzer MS, Heller DS. Large cell neuroendocrine carcinoma of the cervix associated with adenocarcinoma in situ: evidence of a common origin. Int J Gynecol Pathol 2001; 20: 311-312.
15. Yun K, Cho NP, Glassford GN. Large cell neuroendocrine carcinoma of the uterine cervix: a report of a case with coexisting cervical intraepithelial neoplasia and human papillomavirus 16. Pathology 1999; 31: 158-161.
16. Hoskins PJ, Swenerton KD, Pike JA et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 2003; 21: 3495-3501.
17. Ozols RF, Bundy BN, Greer BE et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 2003; 21: 3194-3200.
18. du Bois A, Quinn M, Thigpen T et al. 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann Oncol 2005; 16 (Suppl 8): 7-12.
19. Termrungruanglert W, Kudelka AP, Piamsomboon S et al. Remission of recurrent cervical cancer with paclitaxel and carboplatin: a case report and review of literature. Eur J Gynaecol Oncol 1996; 17: 493-496.
20. Piver MS, Ghamande SA, Eltabbakh GH, O'Neill-Coppola C. First-line chemotherapy with paclitaxel and platinum for advanced and recurrent cancer of the cervix - a phase II study. Gynecol Oncol 1999; 75: 334-337.
21. Moore DH, Blessing JA, McQuellon RP et al. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol 2004; 22: 3113-3119.
22. Gridelli C, Manzione L, Perrone F et al. Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study. Br J Cancer 2001; 84: 38-41.
23. Kakolyris S, Mavroudis D, Tsavaris N et al. Paclitaxel in combination with carboplatin as salvage treatment in refractory small-cell lung cancer (SCLC): a multicenter phase II study. Ann Oncol 2001; 12: 193-197.
24. Tangjitgamol S, Ramirez P, Sun C et al. Expression of HER-2/neu, epidermal growth factor receptor, vascular endothelial growth factor, cyclooxygenase-2, estrogen receptor, and progesterone receptor in small cell and large cell neuroendocrine carcinoma of the uterine cervix: a clinicopathologic and prognostic study. Int J Gynecol Cancer 2005; 15: 1243-1248.